Home/Filings/4/0001635075-25-000005
4//SEC Filing

Ramaswamy Vivek 4

Accession 0001635075-25-000005

CIK 0001635088other

Filed

Nov 16, 7:00 PM ET

Accepted

Nov 17, 5:52 PM ET

Size

9.6 KB

Accession

0001635075-25-000005

Insider Transaction Report

Form 4
Period: 2025-11-13
Transactions
  • Sale

    Common Shares

    2025-11-13$20.81/sh287,283$5,978,35935,221,076 total
  • Sale

    Common Shares

    2025-11-14$20.33/sh1,027,670$20,892,53134,193,406 total
  • Sale

    Common Shares

    2025-11-17$20.51/sh539,650$11,068,22233,653,756 total
Holdings
  • Common Shares

    (indirect: Spousal)
    13,357,857
Footnotes (4)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.54 to $21.08, inclusive. The reporting person undertakes to provide to Roivant Sciences Ltd., any security holder of Roivant Sciences Ltd., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $21.11, inclusive.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.20 to $20.72, inclusive.
  • [F4]Represents the quantity of shares held indirectly only.

Issuer

Roivant Sciences Ltd.

CIK 0001635088

Entity typeother

Related Parties

1
  • filerCIK 0001635075

Filing Metadata

Form type
4
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 5:52 PM ET
Size
9.6 KB